|thanks for replying
Jan 7, 2006
thanks for replying because your kind gesture can save someones life. i just wanna ask you one thing not bother you that much my friend whose cd4 is 165 and vl is 2.5million .he is also a diabetic .i want to ask what drugs should i start and how should i then treat his diabetes whicg haart therapy is best for him.will he have to come on insulin.please let me know the viral drugs which i should try on him thanks. DR SHEHARYAR
| Response from Dr. Young
Thanks for your follow up and kind words.
He should be starting on the most potent, and well tolerated three drug regimen possible. By current conventions, this would mean a regimen of 2 nucleoside drugs with either a non-nuke (efavirenz/Sustiva) or a ritonavir-boosted protease inhibitor (lopinavir/Kaletra; fosamprenavir/Lexiva or atazanavir/Reyataz are popular ones in the states).
The possibility of complicating his diabetes is notable-- to this extent, some of the protease inhibitors can exacerbate sugar control, but generally not to a significant degree. The other issue to note is the possiblity that your friend either has, or is a risk of developing kidney disease (because of diabetes)- tenofovir (Viread or Truvada), if prescribed, should be monitored closely.
It's important, as you suggest, to try to tailor medications to a patient's particular set of needs. Because of this, please make sure that your friend gets good medical advice.
Good luck to you and your friend. BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.